Hoel Andrew W, Kayssi Ahmed, Brahmanandam Soma, Belkin Michael, Conte Michael S, Nguyen Louis L
Division of Vascular Surgery, Brigham & Women's Hospital, Boston, Mass 02115, USA.
J Vasc Surg. 2009 Aug;50(2):349-54. doi: 10.1016/j.jvs.2009.01.012.
Gender and ethnicity are factors affecting the incidence and severity of vascular disease as well as subsequent treatment outcomes. Although well studied in other fields, balanced enrollment of patients with relevant demographic characteristics in vascular surgery randomized controlled trials (RCTs) is not well known. This study describes the reporting of gender and ethnicity data in vascular surgery RCTs and analyzes whether these studies adequately represent our diverse patient population.
We conducted a retrospective review of United States-based RCTs from 1983 through 2007 for three broadly defined vascular procedures: aortic aneurysm repair (AAR), carotid revascularization (CR), and lower extremity revascularization (LER). Included studies were examined for gender and ethnicity data, study parameters, funding source, and geographic region. The Nationwide Inpatient Sample (NIS) database was analyzed to obtain group-specific procedure frequency as an estimate of procedure frequency in the general population.
We reviewed 77 studies, and 52 met our inclusion criteria. Only 85% reported gender, and 21% reported ethnicity. Reporting of ethnicity was strongly associated with larger (>280 participants), multicenter, government-funded trials (P < .001 for all). Women are disproportionately under-represented in RCTs for all procedure categories (AAR, 9.0% vs 21.5%; CR, 30.0% vs 42.9%; LER, 22.4% vs 41.3%). Minorities are under-represented in AAR studies (6.0% vs 10.7%) and CR studies (6.9% vs 9.5%) but are over-represented in LER studies (26.0% vs 21.8%, P < .001 for all).
Minority ethnicity and female gender are under-reported and under-represented in vascular surgery RCTs, particularly in small, non-government-funded and single-center trials. The generalizability of some trial results may not be applicable to these populations. Greater effort to enroll a balanced study population in RCTs may yield more broadly applicable results.
性别和种族是影响血管疾病发病率、严重程度以及后续治疗结果的因素。尽管在其他领域已得到充分研究,但血管外科随机对照试验(RCT)中具有相关人口统计学特征的患者均衡入组情况并不为人熟知。本研究描述了血管外科RCT中性别和种族数据的报告情况,并分析这些研究是否充分代表了我们多样化的患者群体。
我们对1983年至2007年美国开展的RCT进行了回顾性研究,涉及三种广义定义的血管手术:主动脉瘤修复术(AAR)、颈动脉血运重建术(CR)和下肢血运重建术(LER)。对纳入研究的性别和种族数据、研究参数、资金来源及地理区域进行审查。分析全国住院患者样本(NIS)数据库以获取特定组别的手术频率,作为一般人群手术频率的估计值。
我们审查了77项研究,其中52项符合纳入标准。只有85%的研究报告了性别,21%的研究报告了种族。种族报告与规模较大(>280名参与者)、多中心、政府资助的试验密切相关(所有P <.001)。在所有手术类别的RCT中,女性的代表性均明显不足(AAR,9.0%对21.5%;CR,30.0%对42.9%;LER,22.4%对41.3%)。少数族裔在AAR研究(6.0%对10.7%)和CR研究(6.9%对9.5%)中的代表性不足,但在LER研究中的代表性过高(26.0%对21.8%,所有P <.001)。
在血管外科RCT中,少数族裔和女性的报告不足且代表性不足,尤其是在小型、非政府资助和单中心试验中。一些试验结果的普遍性可能不适用于这些人群。在RCT中更努力地纳入均衡的研究人群可能会产生更具广泛适用性的结果。